PHARMEASY · Health Care
▼ ₹45.65 (−89.51%) over all time
Key figures for PharmEasy
PharmEasy is an Indian digital healthcare platform operated by API Holdings that offers e-pharmacy, diagnostics, teleconsultation and health subscriptions. The platform connects consumers with licensed pharmacies and diagnostic labs, enabling medicine delivery, lab tests at home and electronic records. Corporate communications highlight partnerships with healthcare providers, quality checks, data security and programs aimed at affordability and adherence. PharmEasy has pursued growth through acquisitions and service expansion while emphasizing regulatory compliance and pharmacist-led order verification to support safe access to medicines and diagnostics across Indian cities.
PharmEasy is an unlisted company operating in the Health Care sector (E-Pharmacy & Healthtech). PharmEasy is an Indian digital healthcare platform operated by API Holdings that offers e-pharmacy, diagnostics, teleconsultation and health subscriptions. The platform connects consumers with licensed pharmacies and diagnostic labs, enabling medicine delivery, lab tests at home and electronic recor…
The current unlisted market price is ₹5.54 per share with a market capitalisation of approximately ₹9538 crore. The company is currently unlisted and investors should factor in illiquidity risk and longer holding horizons. Investors are advised to review the full financial data and consult an advisor before investing.
Leave your name and mobile, our unlisted shares desk will call you back with live pricing and availability.
Latest source-linked updates that may be relevant to this company.
Dalal Street outlook: Crude oil, Strait of Hormuz and Fed cues to drive stock market this week timesofindia.indiatimes.com
FPIs Invest ₹16,621 Crore in Indian Equities So Far in August News On AIR
Expert view: Markets navigate hormuz risks, FII comeback and policy crosswinds livemint.com
